DERMACYTE Trademark

Trademark Overview


On Tuesday, November 21, 2017, a trademark application was filed for DERMACYTE with the United States Patent and Trademark Office. The USPTO has given the DERMACYTE trademark a serial number of 87693641. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, February 1, 2024. This trademark is owned by Merakris Therapeutics, LLC. The DERMACYTE trademark is filed in the Pharmaceutical Products category with the following description:

Human biological amniotic membrane tissue intended for subsequent implantation; human biological amniotic tissue derived from postpartum tissues that may include amniotic membrane, amniotic fluid, umbilical cord, or placenta, intended for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; human biological tissue, namely, blood, stem cells, umbilical cords and placentas for use in biological tissue grafts for use in surgery and wound repair; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of amniotic mate...
dermacyte

General Information


Serial Number87693641
Word MarkDERMACYTE
Filing DateTuesday, November 21, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, February 1, 2024
Registration Number5507644
Registration DateTuesday, July 3, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements


Goods and ServicesHuman biological amniotic membrane tissue intended for subsequent implantation; human biological amniotic tissue derived from postpartum tissues that may include amniotic membrane, amniotic fluid, umbilical cord, or placenta, intended for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; human biological tissue, namely, blood, stem cells, umbilical cords and placentas for use in biological tissue grafts for use in surgery and wound repair; topical treatment in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of a wound dressing for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; topical treatment made from amniotic material in the nature of an allograft for medical use for the treatment of wounds, ulcers, burns, scars and surgical incisions; wound treatment in the nature of amniotic material prepared in sheet forms or flowable forms

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 4, 2017
Primary Code005
First Use Anywhere DateWednesday, November 8, 2017
First Use In Commerce DateWednesday, November 8, 2017

Trademark Owner History


Party NameMERAKRIS THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressRESEARCH TRIANGLE PARK, NC 27709

Party NameMerakris Therapeutics, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressResearch Triangle Park, NC 27709

Party NameMerakris Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressResearch Triangle Park, NC 27709

Party NameMerakris Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressResearch Triangle Park, NC 27709

Trademark Events


Event DateEvent Description
Thursday, February 1, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, February 1, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, February 1, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 10, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, July 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 25, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 3, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 14, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 6, 2018ASSIGNED TO EXAMINER
Monday, December 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 24, 2017NEW APPLICATION ENTERED